Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
candesartan (atacand) (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
Hypertension (Phase 3)
Trials (1 total)
Trial APIs (2 total)